Tennis Federation mandates female players' gender tests
The Women's Tennis Association has announced an update to its policies, mandating a one-time genetic test to detect the "SRY" gene, which determines biological sex. This measure aims to regulate the participation of female players in tournaments. The test will focus on female competitors and can be conducted through a cheek swab or blood analysis, with implementation starting in 2026. This move comes amid discussions regarding the participation of transgender players, as the previous policy allowed such players to compete provided they declared their gender as "female" and maintained low testosterone levels for two years. Currently, there are no transgender athletes competing professionally under this regulation. The federation emphasizes transparency and data protection, committing to confidentiality, and this update is part of ongoing regulatory efforts to manage the process.
Notice: This Is an AI-Generated Summary
Comments (0)